Understanding how cells manage stress and protein folding in plants
Unfolded protein response in the model species Arabidopsis thaliana
This study looks at how a small plant called Arabidopsis thaliana handles stress and keeps its proteins in shape, which could help us understand similar problems in humans that lead to diseases like cancer and diabetes, with the hope of finding new treatments.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Michigan State University NIH-funded |
| Lab location | 1 site (East Lansing, United States) |
| Project ID | NIH-10831012 on NIH RePORTER |
What this research studies
This research investigates the unfolded protein response (UPR) in the plant species Arabidopsis thaliana, focusing on how cells cope with stress and maintain proper protein folding. By studying this process in a whole-body context, the research aims to uncover mechanisms that could be relevant to human diseases such as cancer and diabetes. The approach involves using advanced genetic and molecular techniques to analyze how disruptions in protein folding can lead to cell death and other harmful conditions. The findings could provide insights into developing new therapies for diseases linked to UPR insufficiency.
Who could benefit from this research
Good fit: Ideal candidates for benefiting from this research include individuals affected by diseases associated with protein misfolding, such as certain cancers and diabetes.
Not a fit: Patients with conditions unrelated to protein folding or the unfolded protein response may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies for treating diseases related to protein misfolding, such as cancer and diabetes.
How similar studies have performed: While the study of the unfolded protein response has been primarily conducted in unicellular organisms, this research aims to explore it in a multicellular context, making it a novel approach.
Where this research is happening
East Lansing, United States
- Michigan State University — East Lansing, United States (Active)
Researchers
- Principal investigator: Brandizzi, Federica — Michigan State University
- Study coordinator: Brandizzi, Federica
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.